cbdMD
Recent News
-
cbdMD Announces Cancellation of Special Meeting
Charlotte, North Carolina--(Newsfile Corp. - October 25, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) announced that it will not proceed with the vote scheduled for October 26, 2023 seeking the approval for the automatic conversion of its Series A Preferred Stock. The special meeting scheduled for that date has been cancelled. While the Company believes converting the Series A Preferred Stock is paramount to future growth and opportunities, it was unable to obtain sufficient "FOR"...
2023-10-25 5:50 PM EDT -
cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team
Charlotte, North Carolina--(Newsfile Corp. - October 5, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced that it will be the official sponsor of the FIFA-affiliated professional Costa Rican soccer team, Club Sport Herediano. This partnership marks the first and only partnership between a CBD brand and a FIFA-recognized premier division professional soccer team.cbdMD was the first CBD company to hold the NSF Certified...
2023-10-05 9:00 AM EDT -
cbdMD Announces Adjournment of Special Meeting
Charlotte, North Carolina--(Newsfile Corp. - September 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) announced that its Special Meeting of Shareholders that convened on September 22, 2023 has been adjourned until October 26, 2023 at 1:00 p.m. (Eastern Time) to solicit additional proxies for its proposal to approve an amendment to the Company's Certificate of Designation for the Series A Preferred Stock to provide that each share of Series A Preferred Stock will be automatically converted into...
2023-09-22 5:02 PM EDT -
Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose
Charlotte, North Carolina--(Newsfile Corp. - September 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's safety data supporting a safe upper dose of its proprietary Broad Spectrum CBD blend. The data was published in Regulatory Toxicology and Pharmacology. The publication includes three separate OECD experiments on rodents performed by a Eurofins lab on the Company's proprietary broad spectrum...
2023-09-22 9:58 AM EDT -
Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023
Your Vote is Important! If you need assistance with voting your shares please contact cbdMD's Investor's Relations team at 1-704-445-3060 or by e-mail at ir@cbdmd.comCharlotte, North Carolina--(Newsfile Corp. - September 14, 2023) - cbdMD, Inc. (NYSE American: YCBD), a highly trusted and recognized cannabidiol (CBD) brand reminds its shareholders to vote ahead of the upcoming special meeting of both Series A preferred as well as common shareholders (the "Meeting") to be held on September 22, 2023 at 1:00 pm (Eastern...
2023-09-14 12:48 PM EDT -
Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award
Charlotte, North Carolina--(Newsfile Corp. - August 25, 2023) - The Pet Innovation Awards has announced that cbdMD, Inc. (NYSE American: YCBD), a highly trusted and recognized cannabidiol (CBD) brand, and its pet products brand, Paw CBD, have been honored with the prestigious "Dog Hip & Joint Product of the Year" award for their Hip+Joint Soft Chews in the 2023 awards program.Paw CBD's Hip+Joint Soft Chews provide essential comfort and care for dogs, supporting mobility and enhancing overall wellbeing. These functional soft...
2023-08-25 9:00 AM EDT -
cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock
Charlotte, North Carolina--(Newsfile Corp. - August 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) today announced that its Board of Directors has suspended the monthly cash dividend payment on the Company's 8.0% Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Stock") beginning with the month ending August 31, 2023, as the Company conserves cash in order to continue its efforts to increase sales, develop additional products, continue research and development and attempt to achieve profitability. ...
2023-08-22 8:30 AM EDT -
cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products
Washington, D.C.--(Newsfile Corp. - August 18, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced its direct response to the Bicameral and Bipartisan Congressional RFI on FDA Regulation of CBD and urges FDA to provide regulatory clarity. On Thursday, July 27th, following a historic hearing on hemp and CBD held by the House Oversight and Accountability Committee, a Request for Information (RFI) Regarding the...
2023-08-18 2:23 PM EDT -
cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million
Charlotte, North Carolina--(Newsfile Corp. - August 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our third quarter of fiscal 2023 results. For the third quarter of fiscal 2023 Net Loss improved to $1.7 million on sales of $6.1 million as compared to a...
2023-08-10 4:48 PM EDT -
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday August 10, 2023, to discuss the company's June 30, 2023 third quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSThursday August 10 2023, 4:30 p.m. Eastern TimeUSA/Canada:
2023-08-07 10:00 AM EDT